ABOUT THE FLAGELLA VISION FOUNDATION
Progess to a Cure
Here at The Fllagella Vision Foundation, we aim to be a catalyst for the equitable advancement of treatment for blindness caused by rare ciliary retinopathies, like the IFT140 gene mutations. The Foundation is committed to fund and accelerate the research and development of gene therapeutics that will create life changing outcomes for those suffering from cilia related blindness. The foundation pursues its mission through partnerships that will help advance patient advocacy and unduly delayed progress to developing gene therapeutics. The Foundation hopes to inspire robust volunteerism in furtherance of its commitment to the collective advancement and equitable access for all to vision care and support.

KEY LEADERS
Where Passion and Dedication Meet

Priyanka Connor
President of the Board

Saurin G. Patel, MD
CEO
